ClearSight Health:
SPOTLIGHT
Fri, Jun 07, 2024
3 minutes read
Interventional Oncology (IO) is undergoing a dynamic transformation, reshaping the way care is delivered to oncology patients across the United States. At the forefront of this evolution is the growing incorporation of Office-Based Labs (OBLs) in the IO sector.
Read More
Thu, Mar 04, 2021
Has COVID-19 pushed medical device sales reps out of the O.R. for good?
Thu, Jun 16, 2022
ClearSight Health at SIR
Thu, Jul 14, 2022
ClearSight Health Employee Spotlight: Rowan Cainer, VP of Growth
Thu, Sep 22, 2022
#TCT2022: Big changes on the horizon for treatment of the “silent killer” that affects nearly half of U.S. adults. Will the U.S. healthcare system be ready?
Tue, Oct 11, 2022
A bright future for risk reduction in TAVR procedures using CEP devices
Thu, Mar 23, 2023
Recalibrating Time and Workload in Medicine: Vital Lessons from AAOS 2023 for the Medical Device Industry
Mon, Apr 24, 2023
Making CRM Work for Medical Device Sales Reps: Modernizing the Medical Device Commercialization Tech Stack
Fri, Jun 07, 2024
Interventional Oncology: The Emergence of Office-Based Labs
Thu, Mar 04, 2021
Has COVID-19 pushed medical device sales reps out of the O.R. for good?
Thu, Jun 16, 2022
ClearSight Health at SIR
Thu, Jul 14, 2022
ClearSight Health Employee Spotlight: Rowan Cainer, VP of Growth
Thu, Sep 22, 2022
#TCT2022: Big changes on the horizon for treatment of the “silent killer” that affects nearly half of U.S. adults. Will the U.S. healthcare system be ready?
Tue, Oct 11, 2022
A bright future for risk reduction in TAVR procedures using CEP devices
Thu, Mar 23, 2023
Recalibrating Time and Workload in Medicine: Vital Lessons from AAOS 2023 for the Medical Device Industry
Mon, Apr 24, 2023
Making CRM Work for Medical Device Sales Reps: Modernizing the Medical Device Commercialization Tech Stack
Fri, Jun 07, 2024
Interventional Oncology: The Emergence of Office-Based Labs
